Partnering with Leading Institutions
INTEGRATED CBD™ is in discussions with leading academic research institutions.
Press Releases Coming Soon.
IN THE PRESS
US National Library of Medicine: Cannabidiol (CBD) inhibits human breast cancer cell proliferation and invasion. They also demonstrated that CBD significantly reduces tumour mass.
Proceedings of the National Academy of Sciences of the United States of America: Recent clinical trials of cannabidiol (CBD) in Dravet syndrome (DS) support its clinical efficacy for reduction of seizure frequency and invite study of its benefits for additional DS symptoms.
U.S. Food and Drug Administration: The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy,